Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US

摘要

IntroductionParticipation in early-phase HIV cure studies includes clinical risks with little to no likelihood of clinical benefit. Examining the willingness of people living with HIV to participate is important to guide study design and informed consent. Our study examined the overall willingness of people living with HIV to participate in HIV cure research in the US, focusing on perceived risks and benefits of participation.